Changing the paradigm of breast cancer treatment: MBQ-167 as a first-in-class metastatic breast cancer therapeutic

Active Project Grant Awarded Last action

Award ID
HT94252310381
Recipient
Awarding agency
Obligated
$4,398,726

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 86% complete
Originally
Place of performance
San Juan, 00927, Puerto Rico

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $4,398,726

Quick answers

Who received award HT94252310381?

HT94252310381 was awarded to MBQ Pharma Inc. by Defense Health Agency (Department of Defense) on May 15, 2023.

How much is award HT94252310381 worth?

$4,398,726 has been obligated on HT94252310381.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award